Alpha-Melanocyte-Stimulating Hormone Immunoreactivity in Human Melanoma Metastases Extracts
β Scribed by GHANEM, G. ;VERSTEGEN, J. ;LIBERT, A. ;ARNOULD, R. ;LEJEUNE, F.
- Book ID
- 111259363
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 489 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0893-5785
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The presence of a-MSH receptors on human melanoma has so far been suggested in the literature but not proved. We describe a reproducible and specific binding assay of a-MSH on human melanoma cells, using a high-specific-activity 1251labelled hormone (1.5 to 2 mCi/pg) with consistent receptor binding
Melanocyte-stimulating hormone (MSH) has been reported to enhance the experimental metastatic behaviour of melanoma cells in the mouse model. alpha-MSH production and MSH receptor (melanocortin 1 receptor gene) expression have been detected in cultured normal human melanocytes and metastasized melan
The common acute lymphoblastic leukemia antigen (CALLA) is identical to human endopeptidase 24.1 I (E-24.1 I) and is expressed on certain human melanoma lines. This work was conducted in order t o investigate whether alphamelanocyte-stimulating hormone (alpha-MSH) could be a substrate for E-24.1 I
D-alpha tocopheryl succinate (vitamin E succinate), which is known to induce differentiation and growth inhibition in murine B-16 melanoma cells, reduced basal and melanocyte-stimulating hormone (MSH)-stimulated adenylate cyclase (AC) activity in vitro. Vitamin E succinate treatment also reduced sod
## Abstract The purpose of our study was to optimize melanoma tumor uptake of ^188^ReβCCMSH and reduce its nonspecific kidney retention. Nephrotoxicity is often a serious problem associated with targeted radiotherapy, therefore, increasing the tumor/kidney uptake ratio of ^188^ReβCCMSH is crucial f